AdaptHealth/AHCO

$9.98

1.31%
-
1D1W1MYTD1YMAX

About AdaptHealth

Adapthealth Corp. provides patient-centered, healthcare-at-home solutions, including home medical equipment (HME), medical supplies and related services. The Company is primarily focused on providing sleep therapy equipment, supplies and related services, including CPAP and bi PAP services to individuals suffering from obstructive sleep apnea (OSA); medical devices and supplies to patients for the treatment of diabetes, including continuous glucose monitors (CGM) and insulin pumps; home medical equipment to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs. The Company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. It serves patients annually in all 50 states through its network of approximately 680 locations in 47 states.

Ticker

AHCO

Sector

Healthcare

Trading on

NASDAQ

Industry

Medical Equipment & Supplies

CEO

Richard Barasch

Employees

10,700

Headquarters

Plymouth meeting, United States

AdaptHealth Metrics

BasicAdvanced
$1.3B
Market cap
-
P/E ratio
-$5.18
EPS
1.08
Beta
-
Dividend rate
$1.3B
1.0821
$15.37
$6.37
1.2M
1.331
1.111
149.147
152.516
41.09%
-14.15%
-38.4%
-15.82%
0.404
0.897
24.629
7.94%
-1,892.87%
44.69%

What the Analysts think about AdaptHealth

Analyst Ratings

Majority rating from 10 analysts.
Buy

Price Targets

Average projection from 10 analysts.
18.74% upside
High $16.00
Low $7.00
$9.98
Current price
$11.85
Average price target

AdaptHealth Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-0.26% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$792M
-7.67%
Net income
-$2.1M
-99.17%
Profit margin
-0.26%
-99.12%

AdaptHealth Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 141.18%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.09
-$3.43
-$1.91
-$0.02
-
Expected
$0.10
$0.19
$0.18
$0.05
$0.15
Surprise
-11.48%
-1,946.93%
-1,178.22%
-141.18%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for AdaptHealth stock?

AdaptHealth (AHCO) has a market cap of $1.3B as of May 18, 2024.

What is the P/E ratio for AdaptHealth stock?

The price to earnings (P/E) ratio for AdaptHealth (AHCO) stock is 0 as of May 18, 2024.

Does AdaptHealth stock pay dividends?

No, AdaptHealth (AHCO) stock does not pay dividends to its shareholders as of May 18, 2024.

When is the next AdaptHealth dividend payment date?

AdaptHealth (AHCO) stock does not pay dividends to its shareholders.

What is the beta indicator for AdaptHealth?

AdaptHealth (AHCO) has a beta rating of 1.08. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

What is the AdaptHealth stock price target?

The target price for AdaptHealth (AHCO) stock is $11.85, which is 18.74% above the current price of $9.98. This is an average based on projections from 10 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell AdaptHealth stock

Buy or sell AdaptHealth stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing